Proteomic analysis of the secretome of Leishmania donovani
about
Exosomes and Other Extracellular Vesicles: The New Communicators in Parasite InfectionsFunctional genomics of trypanosomatidsStructures of Leishmania major orthologues of macrophage migration inhibitory factorCathepsin B gene disruption induced Leishmania donovani proteome remodeling implies cathepsin B role in secretome regulationLeishmania eukaryotic initiation factor (LeIF) inhibits parasite growth in murine macrophagesImmunoinformatics Features Linked to Leishmania Vaccine Development: Data Integration of Experimental and In Silico Studies.Leishmania infantum-chagasi activates SHP-1 and reduces NFAT5/TonEBP activity in the mouse kidney inner medulla.Exocytosis and protein secretion in Trypanosoma.Secretome: clues into pathogen infection and clinical applications.Identification of Leishmania proteins preferentially released in infected cells using change mediated antigen technology (CMAT).Leishmania infantum Exoproducts Inhibit Human Invariant NKT Cell Expansion and ActivationTemperature-induced protein secretion by Leishmania mexicana modulates macrophage signalling and function.Intracellular eukaryotic parasites have a distinct unfolded protein response.Overexpression of a single Leishmania major gene enhances parasite infectivity in vivo and in vitroTLR1/2 activation during heterologous prime-boost vaccination (DNA-MVA) enhances CD8+ T Cell responses providing protection against Leishmania (Viannia)Selective and strain-specific NFAT4 activation by the Toxoplasma gondii polymorphic dense granule protein GRA6.Membrane vesicle release in bacteria, eukaryotes, and archaea: a conserved yet underappreciated aspect of microbial life.In silico work flow for scaffold hopping in LeishmaniaProteomic examination of Leishmania chagasi plasma membrane proteins: Contrast between avirulent and virulent (metacyclic) parasite formsExtracellular vesicles in parasitic diseasesEnolase: a key player in the metabolism and a probable virulence factor of trypanosomatid parasites-perspectives for its use as a therapeutic target.A Trypanosoma brucei kinesin heavy chain promotes parasite growth by triggering host arginase activity.Vaccination with Leishmania infantum acidic ribosomal P0 but not with nucleosomal histones proteins controls Leishmania infantum infection in hamstersIdentification of a secreted casein kinase 1 in Leishmania donovani: effect of protein over expression on parasite growth and virulence.Oligopeptidase B deficient mutants of Leishmania major.The streamlined genome of Phytomonas spp. relative to human pathogenic kinetoplastids reveals a parasite tailored for plantsRegulation of Leishmania (L.) amazonensis protein expression by host T cell dependent responses: differential expression of oligopeptidase B, tryparedoxin peroxidase and HSP70 isoforms in amastigotes isolated from BALB/c and BALB/c nude mice.Small RNAs derived from tRNAs and rRNAs are highly enriched in exosomes from both old and new world Leishmania providing evidence for conserved exosomal RNA Packaging.Immunogenicity evaluation of a rationally designed polytope construct encoding HLA-A*0201 restricted epitopes derived from Leishmania major related proteins in HLA-A2/DR1 transgenic mice: steps toward polytope vaccineIdentification and characterization of genes involved in leishmania pathogenesis: the potential for drug target selection.Coadministration of the Three Antigenic Leishmania infantum Poly (A) Binding Proteins as a DNA Vaccine Induces Protection against Leishmania major Infection in BALB/c MiceDifferential Gene Expression and Infection Profiles of Cutaneous and Mucosal Leishmania braziliensis Isolates from the Same Patient.The Leishmania metaphylome: a comprehensive survey of Leishmania protein phylogenetic relationshipsImmunomodulatory Effects of Four Leishmania infantum Potentially Excreted/Secreted Proteins on Human Dendritic Cells Differentiation and Maturation.From Drug Screening to Target Deconvolution: a Target-Based Drug Discovery Pipeline Using Leishmania Casein Kinase 1 Isoform 2 To Identify Compounds with Antileishmanial Activity.Peroxiredoxins in parasites.Recombinant Forms of Leishmania amazonensis Excreted/Secreted Promastigote Surface Antigen (PSA) Induce Protective Immune Responses in Dogs.Characterization of the M32 metallocarboxypeptidase of Trypanosoma brucei: differences and similarities with its orthologue in Trypanosoma cruzi.Ecotin-like serine peptidase inhibitor ISP1 of Leishmania major plays a role in flagellar pocket dynamics and promastigote differentiation.Comprehensive Identification of mRNA-Binding Proteins of Leishmania donovani by Interactome Capture.
P2860
Q26782503-14662D6C-316B-48CA-AB6F-700816382DFAQ27022024-4FF729A1-7E2D-4BA8-87CE-7341093D9AB4Q27653632-A6B9E1B2-4579-4B49-B8C8-C4F0A80CF7F7Q28535124-64180205-72A1-4B27-8CE9-0504128D39CDQ28538886-44A338D0-DCC6-4095-BE67-EDAE3CF8FBA1Q31162563-C14E21BC-3973-4944-83A2-C8160C4605E6Q31171204-DBABFC49-C8C8-466C-9491-E32A24C87066Q33526674-D852254A-2C9D-4B8B-8CC8-27F9A5670926Q33600144-64A79B6C-CABF-4CB4-92EA-9C68A0AD8077Q33722105-EE758C7B-42FD-413C-BE43-5B4CA6057AE6Q33810033-6FEE5F22-8797-4956-B03A-C4D4E2775E58Q33894695-BEF28170-C857-4953-B99F-DA9F8DED03B8Q33895133-9D5C07BF-AA85-4D6B-BF19-757DB4D14690Q33903394-8283345D-FC76-4E10-9E5A-55FBEA5498A2Q33939303-E7833D41-8DE6-4B00-BE9F-643BDD2074F9Q34230563-5F361D57-FC0E-4E15-9272-331C87F3DE3AQ34260635-D3326C0D-95CD-4310-A30B-4C6BAF8DBC1CQ34584775-A81DEE65-D670-426F-B47E-1B8241DD43EBQ34630037-DF3F8A0A-C600-49FE-8C4E-2163218768CAQ34767634-BC3113FC-4BE2-4751-891F-DE07D50819C9Q34975047-F9D4A007-9CE1-471E-B3DE-DC14CFBD2373Q35034254-CF8C125C-E35E-4E6B-AC94-05556D41F07AQ35038313-9E3A2B74-FC84-452D-8E52-1561D11D72F4Q35048303-33D148BF-9214-4584-8E0A-253DA75391C1Q35089762-47592F8E-A300-4425-85E7-B3F227FF29AFQ35091250-EB530A6E-03BD-4B26-A5E2-300AF9CA9A6EQ35097514-1A6CE924-B1F6-46C9-9F25-20164098A297Q35156278-A9A028A6-00E0-47EC-B95E-9A7754EED7B2Q35326248-EEFA8187-DB1E-4274-9867-B14885F2315DQ35430594-FFD687AE-ECC1-44D7-9A00-0A2FD4BC725AQ35587034-B0827BED-63E7-4E1B-BF47-AF1EC6CB14E4Q35772188-97A7BA3F-8D27-45BD-9C26-9B9FBCCBBE94Q35827646-C29789AE-796E-44E8-8776-BB46FD7ED645Q35845442-83DE9748-6C6E-47BD-9DD0-AE9A25F107F8Q35931675-9E8D6319-A7D0-482A-8C1E-A6810B5040ACQ36026850-5197DECA-FD34-422F-AECB-2B7054616C9CQ36028999-2103CAF1-9F1A-404E-B369-B1FEBF8CE2E7Q36059069-62F69AD7-2680-4F2F-A4BF-C246522914B5Q36230322-4BBC57B6-E256-4ACF-A735-6DF283C42818Q36263867-A6E3D42A-8FA1-4145-A129-A32A84CD3BC5
P2860
Proteomic analysis of the secretome of Leishmania donovani
description
2008 nî lūn-bûn
@nan
2008 թուականին հրատարակուած գիտական յօդուած
@hyw
2008 թվականին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Proteomic analysis of the secretome of Leishmania donovani
@ast
Proteomic analysis of the secretome of Leishmania donovani
@en
Proteomic analysis of the secretome of Leishmania donovani
@en-gb
Proteomic analysis of the secretome of Leishmania donovani
@nl
type
label
Proteomic analysis of the secretome of Leishmania donovani
@ast
Proteomic analysis of the secretome of Leishmania donovani
@en
Proteomic analysis of the secretome of Leishmania donovani
@en-gb
Proteomic analysis of the secretome of Leishmania donovani
@nl
prefLabel
Proteomic analysis of the secretome of Leishmania donovani
@ast
Proteomic analysis of the secretome of Leishmania donovani
@en
Proteomic analysis of the secretome of Leishmania donovani
@en-gb
Proteomic analysis of the secretome of Leishmania donovani
@nl
P2093
P2860
P3181
P356
P1433
P1476
Proteomic analysis of the secretome of Leishmania donovani
@en
P2093
Dale P Robinson
Dennis M Dwyer
Devki Nandan
J Maxwell Silverman
Leonard J Foster
Neil E Reiner
Simon K Chan
P2860
P2888
P3181
P356
10.1186/GB-2008-9-2-R35
P407
P577
2008-01-01T00:00:00Z
P5875
P6179
1037866253